Insights on novel particulate self-assembled drug delivery beads based on partial inclusion complexes between triglycerides and cyclodextrins

References

• Aburahma MH, El-Laithy HM, Hamza YE. (2010). Oral bioavailability enhancement of vinpocetine using self-microemulsifying drug delivery system containing long chain triglycerides: preparation and in vitro/in vivo evaluation. Clin Res Regul Aff 27:97–107
   Google Scholar
• Ali Khan A, Mudassir J, Mohtar N, Darwis Y. (2013). Advanced drug delivery to the lymphatic system: lipid-based nanoformulations. Int J Nanomed 8:2733–44
   PubMed Web of Science ®Google Scholar
• Arima H, Motoyama K, Irie T. (2011). Recent findings on safety profiles of cyclodextrins, cyclodextrin conjugates, and polypseudorotaxanes. In: Bilensoy E, ed. Cyclodextrins in pharmaceutics, cosmetics, and biomedicine: current and future industrial applications. Hoboken (NJ): Wiley, 91–122
   Google Scholar
• Ascenso A, Cruz M, Euletério C, et al. (2013). Novel tretinoin formulations: a drug-in-cyclodextrin-in-liposome approach. J Liposome Res 23:211–19
   PubMed Web of Science ®Google Scholar
• Bochot A, Trichard L, Le Bas G, et al. (2007). α-cyclodextrin/oil beads: an innovative self-assembling system. Int J Pharm 339:121–9
   PubMed Web of Science ®Google Scholar
• Brewster ME, Loftsson T. (2007). Cyclodextrins as pharmaceutical solubilizers. Adv Drug Deliv Rev 59:645–66
   PubMed Web of Science ®Google Scholar
• Brown MB, Martin GP, Jones SA, Akomeah FK. (2006). Dermal and transdermal drug delivery systems: current and future prospects. Drug Deliv 13:175–87
   PubMed Web of Science ®Google Scholar
• Bondì ML, Fontana G, Carlisi B, Giammona G. (2003). Preparation and characterization of solid lipid nanoparticles containing cloricromene. Drug Deliv 10:245–50
   PubMed Web of Science ®Google Scholar
• Cable CG. (2009). Soybean oil. In: Rowe RC, Sheskey PJ, Owen SC, eds. Handbook of pharmaceutical excipients, 6th ed. Washington (DC): American Pharmaceutical Association, 682–5
   Google Scholar
• Carlier H, Bernard A, Caselli C. (1991). Digestion and absorption of polyunsaturated fatty acids. Reprod Nutr Dev 31:475–500
   PubMedGoogle Scholar
• Challa R, Ahuja A, Ali J, Khar RK. (2005). Cyclodextrins in drug delivery: an updated review. AAPS PharmSciTech 6:E329–57
   PubMed Web of Science ®Google Scholar
• Chang D, Chang R. (2007). Review of current issues in pharmaceutical excipients. Pharmaceut Technol. Available from: http://pharmtech.findpharma.com/pharmtech/article/articleDetail.jsp?id=423551&pageID=1&sk=&date [last accessed 29 Jun 2014]
   Google Scholar
• Chavhan SS, Petkar KC, Sawant KK. (2013). Simvastatin nanoemulsion for improved oral delivery: design, characterisation, in vitro and in vivo studies. J Microencapsul 30:771–9
   PubMed Web of Science ®Google Scholar
• Chen FJ, Etzler FM, Ubben J, et al. (2010). Effects of lipophilic components on the compatibility of lipid-based formulations with hard gelatin capsules. J Pharm Sci 99:128–41
   PubMed Web of Science ®Google Scholar
• Chen J, Lu WL, Gu W, et al. (2014). Drug-in-cyclodextrin-in-liposomes: a promising delivery system for hydrophobic drugs. Expert Opin Drug Deliv 11:565–77
   PubMed Web of Science ®Google Scholar
• Chen ML. (2008). Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective. Adv Drug Deliv Rev 60:768–77
   PubMed Web of Science ®Google Scholar
• Coleman AW, Nicolis I, Keller N, Dalbiez JP. (1992). Aggregation of cyclodextrins: an explanation of the abnormal solubility of b-cyclodextrin. J Incl Phenom Macrocycl Chem 13:139–43
   Web of Science ®Google Scholar
• Crevel RW, Kerkhoff MA, Koning MM. (2000). Allergenicity of refined vegetable oils. Food Chem Toxicol 38:385–93
   PubMed Web of Science ®Google Scholar
• de Smidt JH, Offringa JC, Crommelin DJ. (1991). Dissolution rate of griseofulvin in bile salt solutions. J Pharm Sci 80:399–401
   PubMed Web of Science ®Google Scholar
• Duchêne D, Bochot A, Yu SC, et al. (2003). Cyclodextrins and emulsions. Int J Pharm 266:85–90
   PubMed Web of Science ®Google Scholar
• European Pharmacopoeia Commission. (2004). European Pharmacopoeia, 5th ed. Strasbourg Cedex, France: Council of Europe
   Google Scholar
• Fatouros DG, Mullertz A. (2008). In vitro lipid digestion models in design of drug delivery systems for enhancing oral bioavailability. Expert Opin Drug Metab Toxicol 4:65–76
   PubMed Web of Science ®Google Scholar
• Fernandes CM, Teresa Vieira M, Veiga FJ. (2002). Physicochemical characterization and in vitro dissolution behavior of nicardipine-cyclodextrins inclusion compounds. Eur J Pharm Sci 15:79–88
   PubMed Web of Science ®Google Scholar
• Fontana G, Maniscalco L, Schillaci D, et al. (2005). Solid lipid nanoparticles containing tamoxifen characterization and in vitro antitumoral activity. Drug Deliv 12:385–92
   PubMed Web of Science ®Google Scholar
• Groo AC, Saulnier P, Gimel JC, et al. (2013). Fate of paclitaxel lipid nanocapsules in intestinal mucus in view of their oral delivery. Int J Nanomed 8:4291–302
   PubMed Web of Science ®Google Scholar
• Gupta M, Tiwari S, Vyas SP. (2013). Influence of various lipid core on characteristics of SLNs designed for topical delivery of fluconazole against cutaneous candidiasis. Pharm Dev Technol 18:550–9
   PubMed Web of Science ®Google Scholar
• Hamoudi M, Fattal E, Gueutin C, et al. (2011). Beads made of cyclodextrin and oil for the oral delivery of lipophilic drugs: in vitro studies in simulated gastro-intestinal fluids. Int J Pharm 416:507–14
   PubMed Web of Science ®Google Scholar
• Hamoudi MC, Bochot A. (2014). Oil-cyclodextrin based beads for oral delivery of poorly-soluble drugs. Curr Top Med Chem 14:510–17
   PubMed Web of Science ®Google Scholar
• Hamoudi MC, Bourasset F, Domergue-Dupont V, et al. (2012). Formulations based on alpha cyclodextrin and soybean oil: an approach to modulate the oral release of lipophilic drugs. J Contr Rel 161:861–7
   PubMed Web of Science ®Google Scholar
• Hamoudi MC, Saunier J, Gueutin C, et al. (2013). Beads made of α-cyclodextrin and soybean oil: the drying method influences bead properties and drug release. Drug Dev Ind Pharm 39:1306–14
   PubMed Web of Science ®Google Scholar
• Han B, Yang B, Yang X, et al. (2014). Host-guest inclusion system of norathyriol with β-cyclodextrin and its derivatives: preparation, characterization, and anticancer activity. J Biosci Bioeng 117:775–9
   PubMed Web of Science ®Google Scholar
• Hauss DJ. (2007). Oral lipid-based formulations. Adv Drug Deliv Rev 59:667–76
   PubMed Web of Science ®Google Scholar
• Hincal AA, Eroğlu H, Bilensoy E. (2011). Regulatory status of cyclodextrins in pharmaceutical products. In: Bilensoy E, ed. Cyclodextrins in pharmaceutics, cosmetic, and biomedicine: current and future industrial applications. Hoboken (NJ): John Wiley and Sons, 123–30
   Google Scholar
• Hu L, Tang X, Cui F. (2004). Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs. J Pharm Pharmacol 56:1527–35
   PubMed Web of Science ®Google Scholar
• Karasulu HY, Karasulu E, Büyükhelvacıgil M, et al. (2011). Soybean oil: production process, benefits and uses in pharmaceutical dosage form, soybean and health. In: El-Shemy H, ed. InTech, Chapter 13; 283–310. Available from: http://www.intechopen.com/books/soybean-and-health/soybean-oil-productionprocess-benefits-and-uses-in-pharmaceutical-dosage-form
   Google Scholar
• Irie T, Uekama K. (1997). Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation. J Pharm Sci 86:147–62
   PubMed Web of Science ®Google Scholar
• Ismail AA, Van de Voort FR, Emo G, Sedman J. (1993). Rapid quantitative determination of free fatty acids in fats and oils by fourier transform infrared spectroscopy. J Am Oil Chem Soc 70:335–41
   Web of Science ®Google Scholar
• Jia LJ, Zhang DR, Li ZY, et al. (2010). Preparation and characterization of silybin-loaded nanostructured lipid carriers. Drug Deliv 17:11–18
   PubMed Web of Science ®Google Scholar
• Kalasz H, Antal I. (2006). Drug excipients. Curr Med Chem 13:2535–63
   PubMed Web of Science ®Google Scholar
• Kanwar JR, Long BM, Kanwar RK. (2011). The use of cyclodextrins nanoparticles for oral delivery. Curr Med Chem 18:2079–85
   PubMed Web of Science ®Google Scholar
• Kawasaki J, Satou D, Takagaki T, et al. (2007). Structural features of inclusion complexes of ɣ-cyclodextrin with various polymers. Polymer 48:1127–38
   Web of Science ®Google Scholar
• Kossena GA, Charman WN, Boyd BJ, et al. (2004). Probing drug solubilization patterns in the gastrointestinal tract after administration of lipid-based delivery systems: a phase diagram approach. J Pharm Sci 93:332–48
   PubMed Web of Science ®Google Scholar
• Kuentz M. (2012). Lipid-based formulations for oral delivery of lipophilic drugs. Drug Discov Today Technol 9:e171–4
   Google Scholar
• Kumura H, Okada M, Kawaguchi Y, Harada A. (2000). Complex formation between poly(dimethylsiloxane) and cyclodextrins: new pseudo-polyrotaxanes containing inorganic polymers. Macromolecules 33:4297–8
   Web of Science ®Google Scholar
• Kurkov SV, Loftsson T. (2013). Cyclodextrins. Int J Pharm 453:167–80
   PubMed Web of Science ®Google Scholar
• Larsen AT, Sassene P, Müllertz A. (2011). In vitro lipolysis models as a tool for the characterization of oral lipid and surfactant based drug delivery systems. Int J Pharm 417:245–55
   PubMed Web of Science ®Google Scholar
• Loftsson T, Brewster ME. (1996). Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J Pharm Sci 85:1017–25
   PubMed Web of Science ®Google Scholar
• Loftsson T, Duchêne D. (2007). Cyclodextrins and their pharmaceutical applications. Int J Pharm 329:1–11
   PubMed Web of Science ®Google Scholar
• Loftsson T, Másson M, Brewster ME. (2004). Self-association of cyclodextrins and cyclodextrin complexes. J Pharm Sci 93:1091–9
   PubMed Web of Science ®Google Scholar
• Mandpe L, Pokharkar V. (2013). Quality by design approach to understand the process of optimization of iloperidone nanostructured lipid carriers for oral bioavailability enhancement. Pharm Dev Technol 2013:1–10. [Epub ahead of print]
   Google Scholar
• Marangoci N, Farcas A, Pinteala M, et al. (2009). Synthesis, morphology, and thermal behavior of polyrotaxanes composed of γ-cyclodextrin and polydimethylsiloxanes. J Incl Phenom Macrocycl Chem 63:355–64
   Web of Science ®Google Scholar
• Mathapa BG, Paunov VN. (2013). Cyclodextrin stabilised emulsions and cyclodextrinosomes. Phys Chem Chem Phys 15:17903–14
   PubMed Web of Science ®Google Scholar
• Melveger AJ, Huynh-Ba K. (2009). Critical regulatory requirements for a stability program, chapter 2. In: Kim Huynh-Ba, ed. Handbook of stability testing in pharmaceutical development. New York, NY: Springer, 9–19
   Google Scholar
• Messner M, Kurkov SV, Jansook P, Loftsson T. (2010). Self-assembled cyclodextrin aggregates and nanoparticles. Int J Pharm 387:199–208
   PubMed Web of Science ®Google Scholar
• Mu H, Holm R, Müllertz A. (2013). Lipid-based formulations for oral administration of poorly water-soluble drugs. Int J Pharm 453:215–24
   PubMed Web of Science ®Google Scholar
• Mu H, Høy CE. (2001). Intestinal absorption of specific structured triacylglycerols. J Lipid Res 42:792–8
   PubMed Web of Science ®Google Scholar
• Muñoz Botella S, Martìn MA, del Castillo B, et al. (1996). Analytical applications of retinoid-cyclodextrin inclusion complexes. 1. Characterization of a retinal-beta-cyclodextrin complex. J Pharm Biomed Anal 14:909–15
   PubMed Web of Science ®Google Scholar
• Noltemeyer M, Saenger W. (1980). Structural chemistry of linear α-cyclodextrin-polyiodide complexes. X-ray crystal structures of (α-cyclodextrin)2. LiI3. I2. 8H2O and (α-cyclodextrin)2. Cd0. 5. I5. 27H2O. Models for the blue amylose–iodine complex. J Am Chem Soc 102:2710–22
   Web of Science ®Google Scholar
• Nordskog BK, Phan CT, Nutting DF, Tso P. (2001). An examination of the factors affecting intestinal lymphatic transport of dietary lipids. Adv Drug Deliv Rev 50:21–44
   PubMed Web of Science ®Google Scholar
• Pando D, Caddeo C, Manconi M, et al. (2013). Nanodesign of olein vesicles for the topical delivery of the antioxidant resveratrol. J Pharm Pharmacol 65:1158–67
   PubMed Web of Science ®Google Scholar
• Parhi R, Suresh P. (2012). Preparation and characterization of solid lipid nanoparticles-a review. Curr Drug Discov Technol 9:2–16
   PubMedGoogle Scholar
• Perret F, Duffour M, Chevalier Y, Parrot-Lopez H. (2013). Design, synthesis, and in vitro evaluation of new amphiphilic cyclodextrin-based nanoparticles for the incorporation and controlled release of acyclovir. Eur J Pharm Biopharm 83:25–32
   PubMed Web of Science ®Google Scholar
• Porbeni FE, Edeki EM, Shin ID, Tonelli AE. (2001). Formation and characterization of the inclusion complexes between poly(dimethylsiloxane) and polyacrylonitrile and ɣ-cyclodextrin. Polymer 42:6907–12
   Web of Science ®Google Scholar
• Porter CJ, Trevaskis NL, Charman WN. (2007). Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov 6:231–48
   PubMed Web of Science ®Google Scholar
• Poullain-Termeau S, Crauste-Manciet S, Brossard D, et al. (2008). Effect of oil-in-water submicron emulsion surface charge on oral absorption of a poorly water-soluble drug in rats. Drug Deliv 15:503–14
   PubMed Web of Science ®Google Scholar
• Seo YG, Kim DH, Ramasamy T, et al. (2013). Development of docetaxel-loaded solid self-nanoemulsifying drug delivery system (SNEDDS) for enhanced chemotherapeutic effect. Int J Pharm 452:412–20
   PubMed Web of Science ®Google Scholar
• Shangguan M, Lu Y, Qi J, et al. (2014). Binary lipids-based nanostructured lipid carriers for improved oral bioavailability of silymarin. J Biomater Appl 28:887–96
   PubMed Web of Science ®Google Scholar
• Sharma N, Baldi A. (2014). Exploring versatile applications of cyclodextrins: an overview. Drug Deliv 2014:1–19. [Epub ahead of print]
   Google Scholar
• Shimada K, Kawano K, Ihsii J, Nakamura T. (1992). Structure of inclusion complexes of cyclodextrins with triglyceride at vegetable oil/water interface. J Food Sci 57:655–6
   Web of Science ®Google Scholar
• Shimada K, Ohe Y, Ohguni T, et al. (1991). Emulsifying properties of alpha-, beta- and gamma-cyclodextrins. Nippon Shokuhin Kogyo Gakkaishi 38:16–20
   Web of Science ®Google Scholar
• Shukla D, Chakraborty S, Singh S, Mishra B. (2011). Lipid-based oral multiparticulate formulations - advantages, technological advances and industrial applications. Expert Opin Drug Deliv 8:207–24
   PubMed Web of Science ®Google Scholar
• Silva AC, Kumar A, Wild W, et al. (2012). Long-term stability, biocompatibility and oral delivery potential of risperidone-loaded solid lipid nanoparticles. Int J Pharm 436:798–805
   PubMed Web of Science ®Google Scholar
• Singh B, Khurana L, Bandyopadhyay S, et al. (2011). Development of optimized self-nano-emulsifying drug delivery systems (SNEDDS) of carvedilol with enhanced bioavailability potential. Drug Deliv 18:599–612
   PubMed Web of Science ®Google Scholar
• Singh I, Swami R, Khan W, Sistla R. (2014). Lymphatic system: a prospective area for advanced targeting of particulate drug carriers. Expert Opin Drug Deliv 11:211–29
   PubMed Web of Science ®Google Scholar
• Stella VJ, He Q. (2008). Cyclodextrins. Toxicol Pathol 36:30–42
   PubMed Web of Science ®Google Scholar
• Strickley RG. (2004). Solubilizing excipients in oral and injectable formulations. Pharm Res 21:201–30
   PubMed Web of Science ®Google Scholar
• Sun H, Liu K, Liu W, et al. (2012). Development and characterization of a novel nanoemulsion drug-delivery system for potential application in oral delivery of protein drugs. Int J Nanomed 7:5529–43
   PubMed Web of Science ®Google Scholar
• Szente L, Szejtli J, Szeman J, Kato L. (1993). Fatty-acid cyclodextrin complexes: properties and applications. J Inclus Phenom Mol 16:339–54
   Web of Science ®Google Scholar
• Thomson AB, Schoeller C, Keelan M, et al. (1993). Lipid absorption: passing through the unstirred layers, brush-border membrane, and beyond. Can J Physiol Pharmacol 71:531–55
   PubMed Web of Science ®Google Scholar
• Tian H, Yao X, Zeng R, et al. (2013). Safety and efficacy of a new parenteral lipid emulsion (SMOF) for surgical patients: a systematic review and meta-analysis of randomized controlled trials. Nutr Rev 71:815–21
   PubMed Web of Science ®Google Scholar
• Tiwari SB, Amiji MM. (2006). Improved oral delivery of paclitaxel following administration in nanoemulsion formulations. J Nanosci Nanotechnol 6:3215–21
   PubMed Web of Science ®Google Scholar
• Tran TH, Ramasamy T, Cho HJ, et al. (2014). Formulation and optimization of raloxifene-loaded solid lipid nanoparticles to enhance oral bioavailability. J Nanosci Nanotechnol 14:4820–31
   PubMed Web of Science ®Google Scholar
• Trichard L, Chaminade P, Grossiord JL, et al. (2011). Beads made of alpha-cyclodextrin and vegetable oils: oil composition and physicochemical properties influence bead feasibility and properties. J Drug Deliv Sci Tec 21:189–94
   Web of Science ®Google Scholar
• Trichard L, Delgado-Charro MB, Guy RH, et al. (2008a). Novel beads made of alpha-cyclodextrin and oil for topical delivery of a lipophilic drug. Pharm Res 25:435–40
   PubMed Web of Science ®Google Scholar
• Trichard L, Fattal E, Besnard M, Bochot A. (2007). α-cyclodextrin/oil beads as a new carrier for improving the oral bioavailability of lipophilic drugs. J Control Release 122:47–53
   PubMed Web of Science ®Google Scholar
• Trichard L, Fattal E, Le Bas G, et al. (2008b). Formulation and characterisation of beads prepared from natural cyclodextrins and vegetable, mineral or synthetic oils. Int J Pharm 354:88–94
   PubMed Web of Science ®Google Scholar
• Van de Voort FR, Ismail AA, Sedman J, Emo G. (1994). Monitoring the oxidation of edible oils by Fourier transform infrared spectroscopy. J Am Oil Chem Soc 71:243–53
   Web of Science ®Google Scholar
• Vergote GJ, Kiekens F, Vervaet C, Remon JP. (2002). Wax beads as cushioning agents during the compression of coated diltiazem pellets. Eur J Pharm Sci 17:145–51
   PubMed Web of Science ®Google Scholar
• Wang Q, Cheng H, Zhou K, et al. (2013). Nanostructured lipid carriers as a delivery system of biochanin A. Drug Deliv 20:331–7
   PubMed Web of Science ®Google Scholar
• Wei L, Sun P, Nie S, Pan W. (2005). Preparation and evaluation of SEDDS and SMEDDS containing carvedilol. Drug Dev Ind Pharm 31:785–94
   PubMed Web of Science ®Google Scholar
• Yap KL, Liu X, Thenmozhiyal JC, Ho PC. (2005). Characterization of the 13-cis-retinoic acid/cyclodextrin inclusion complexes by phase solubility, photostability, physicochemical and computational analysis. Eur J Pharm Sci 25:49–56
   PubMed Web of Science ®Google Scholar
• Yu SC, Bochot A, Bas GL, et al. (2001). Characteristics of o/w emulsions containing lipophilic molecules with cyclodextrins as emulsifiers. STP Pharm Sci 11:385–91
   Google Scholar
• Yu SC, Bochot A, Bas GL, et al. (2003). Effect of camphor/cyclodextrin complexation on the stability of O/W/O multiple emulsions. Int J Pharm 261:1–8
   PubMed Web of Science ®Google Scholar
• Zhang D, Luob G, Ding X, Lu C. (2012). Preclinical experimental models of drug metabolism and disposition in drug discovery and development. Acta Pharmaceutica Sinica B 2:549–61
   Google Scholar
• Zhao YQ, Wang LP, Ma C, et al. (2013). Preparation and characterization of tetrandrine-phospholipid complex loaded lipid nanocapsules as potential oral carriers. Int J Nanomed 8:4169–81
   PubMed Web of Science ®Google Scholar
• Zhuang CY, Li N, Wang M, et al. (2010). Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability. Int J Pharm 394:179–85
   PubMed Web of Science ®Google Scholar